Key Takeaways
CPT Code 55866 describes laparoscopic radical prostatectomy, retropubic approach, with nerve sparing and optional robotic assistance.
This is an inpatient-only procedure under CMS guidelines; it cannot be billed in an outpatient or ASC setting under Medicare.
NCCI bundles several prostate codes with 55866, including urethral suspension (51992); unbundling without proper documentation triggers denials.
Pabau’s claims management software helps urology practices track modifier requirements and NCCI edits to reduce CPT 55866 denials.
Denied claims for laparoscopic radical prostatectomy rarely come from miscoding the primary procedure. They come from missing a modifier, pairing the code with an unsupported diagnosis, or unknowingly violating an NCCI bundling edit. For urology billers, CPT Code 55866 carries more documentation complexity than most surgical codes in the section, and the stakes are high: reimbursement for this procedure runs in the thousands of dollars per claim.
This billing reference covers the full descriptor for CPT Code 55866, the 2026 AMA descriptor revision, Medicare reimbursement and RVU data, applicable modifiers, NCCI bundling edits, medical necessity ICD-10 codes, the 55866 vs. 55867 distinction, and documentation requirements for clean claims. Urology coders and practice managers will find this a practical reference for avoiding the most common denial patterns.
CPT Code 55866: Definition and Clinical Description
CPT Code 55866 is maintained by the American Medical Association (AMA) under the Current Procedural Terminology (CPT) code set. The pre-2026 descriptor reads: Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed.
The AMA revised CPT Code 55866 for the 2026 code year. According to AAPC’s My Urology Coding Alert (November 2025), the descriptor language received subtle updates under the prostate laparoscopy subsection of the 2026 CPT codebook. Coders should reference the current AMA 2026 CPT codebook for the precise updated descriptor language before submitting claims for dates of service on or after January 1, 2026.
Clinically, CPT Code 55866 covers a laparoscopic approach to radical prostatectomy in which the surgeon removes the entire prostate gland and, when technically feasible, preserves the neurovascular bundles responsible for erectile function. The procedure is performed via small laparoscopic ports and may incorporate robotic assistance (most commonly the da Vinci Surgical System). Robotic assistance is explicitly included within the code’s global package and cannot be billed separately. For men’s health clinics and urology practices that perform high volumes of robotic prostatectomy, this bundling distinction is one of the most frequent sources of billing confusion.
Code Range Context: 55866-55869
CPT Code 55866 sits within the laparoscopic prostate procedures subsection (55866-55869). Understanding the range helps coders select the correct code when multiple procedures are documented:
| CPT Code | Short Descriptor | Key Distinction |
|---|---|---|
| 55866 | Laparoscopic radical prostatectomy, retropubic, with nerve sparing, robotic assistance included | Radical intent; cancer cases; robotic included |
| 55867 | Laparoscopic simple prostatectomy (effective January 1, 2023) | Simple/subtotal removal; BPH cases; not radical |
| 55868 | Laparoscopic prostatectomy with pelvic lymph node dissection | Add-on considerations; verify current descriptor |
| 55869 | Additional laparoscopic prostate procedure | Verify per current AMA codebook |
CPT 55866 vs. 55867: Radical vs. Simple Prostatectomy
Before 2023, coders performing a laparoscopic simple prostatectomy had no dedicated code and were forced to use unlisted procedure codes. CPT Code 55867 became effective January 1, 2023, creating a clean distinction between radical and simple laparoscopic prostatectomy billing. Selecting the wrong code between 55866 and 55867 is one of the most consequential errors in urology coding because the clinical indications, global package considerations, and reimbursement amounts differ significantly.
- 55866 (Radical): Used when the surgical intent is curative removal of the prostate for malignancy. Primary diagnosis is typically prostate cancer (ICD-10 C61). Includes nerve sparing and robotic assistance when performed.
- 55867 (Simple/Subtotal): Used for non-oncologic indications such as benign prostatic hyperplasia (BPH) causing obstruction. The procedure removes obstructing prostatic tissue but is not intended as a cancer cure.
- Key test: If the operative report documents “radical” intent, nerve-sparing technique, and a malignancy indication, use 55866. If the report documents a subtotal resection for BPH, use 55867. Adding modifier 52 to 55866 to downgrade a radical to a simple procedure is incorrect coding practice, per AAPC guidance.
Using the wrong code between these two carries both financial and compliance risk. Overcoding 55867 cases as 55866 may trigger upcoding reviews. Undercoding 55866 cases as 55867 leaves significant reimbursement on the table. The operative report and the admitting diagnosis together determine the correct selection. For practices that also bill other complex surgical procedure codes, the same principle applies: the documented clinical intent drives code selection, not the surgical approach alone.
CPT Code 55866 Reimbursement and Medicare Fee Schedule
CPT Code 55866 carries a high relative value unit (RVU) total, reflecting the procedure’s complexity, operative time, and global surgical package obligations. The CMS Physician Fee Schedule lookup tool provides the current year’s allowable amounts by geographic area. National payment rates vary by Medicare Administrative Contractor (MAC) locality, so the figures below represent approximate national averages and should be confirmed against the current MPFS before claim submission.
| Component | Approximate Value (National Average) | Notes |
|---|---|---|
| Work RVUs | Approximately 35-40 wRVUs | Reflects high surgical complexity |
| Global Period | 90 days | Major surgery global package applies |
| Medicare Allowable (facility) | Varies by MAC locality | Use CMS PFS search tool for current year |
| Place of Service | Inpatient only (POS 21) | CMS inpatient-only list; cannot bill in ASC |
For precise 2026 RVU values and converted dollar amounts, use the FastRVU 2026 RVU lookup tool, which pulls directly from CMS data and applies geographic practice cost index (GPCI) multipliers by locality. Reimbursement amounts change annually when CMS publishes the final MPFS rule each November.
Inpatient-only designation: CPT Code 55866 appears on the CMS inpatient-only (IPO) list. This means Medicare will not reimburse for this procedure when performed in an ambulatory surgery center (ASC) or outpatient hospital setting. Claims submitted with an outpatient place of service for Medicare patients are subject to automatic denial without appeal rights under the current IPO policy framework. Verify the IPO list annually, as CMS updates it each calendar year.
Pro Tip
Run a place-of-service audit on all CPT 55866 claims quarterly. Any claim submitted with POS 22 (outpatient hospital) or POS 24 (ASC) for Medicare patients will deny automatically. Catching these before submission prevents write-offs that cannot be appealed under IPO policy rules.
CPT Code 55866 Modifiers
Modifier selection for CPT Code 55866 follows standard surgical coding rules, with a few urology-specific considerations that affect claim outcomes. Using the wrong modifier, or omitting one when required, is a primary driver of downcoded and denied claims for laparoscopic prostatectomy. Accurate documentation of the correct diagnosis code and modifier pairing is essential before submission.
- Modifier 22 (Increased Procedural Services): Append when the procedure required substantially more work than typically described, such as prior pelvic radiation, extensive adhesions from prior surgery, or morbid obesity. Requires detailed documentation in the operative note explaining the added complexity. Payers may request records before approving the additional payment.
- Modifier 52 (Reduced Services): Not appropriate for downgrading a radical prostatectomy to a simple one. May apply in rare scenarios where the planned procedure was curtailed due to intraoperative findings. Per AAPC guidance, 55866 with modifier 52 does not convert the code to simple prostatectomy billing.
- Modifier 80 (Assistant Surgeon): Applies when a physician assistant surgeon participates. Medicare covers assistant surgeon services for 55866 under the global package rules. Verify coverage for commercial payers separately.
- Modifier AS (PA/NP/CRNA as Assistant Surgeon): Used when a PA, NP, or CRNA assists rather than a physician. Reimbursement is typically 85% of the assistant surgeon allowable.
- Modifier 78 (Unplanned Return to Operating Room): Applies when a patient requires a return to the operating room for a complication during the 90-day global period. Without this modifier, the second procedure denies as included in the global package.
NCCI Bundling Edits for CPT Code 55866
The Centers for Medicare and Medicaid Services (CMS) National Correct Coding Initiative (NCCI) Policy Manual, Chapter 7 (2025), explicitly lists CPT Code 55866 within the prostate procedure code group subject to bundling edits. These edits determine which codes can and cannot be billed together on the same date of service without a modifier override.
The most clinically relevant bundling scenario involves urethral suspension (CPT Code 51992). According to NCCI policy, the two codes share a bundling relationship, meaning 51992 is generally considered part of the surgical package when performed with 55866. Research published in JAMA Network Open analyzed trends in urethral suspension with robotic prostatectomy in Medicare claims data, finding that CMS policy changes affected billing patterns for concurrent urethral suspension procedures. Whether 51992 can be separately reported with a modifier depends on the current NCCI modifier indicator for this code pair. Billers should verify the modifier indicator in the current NCCI table before submitting both codes together.
Laparoscopic pelvic lymph node dissection (CPT Code 38771) is frequently performed alongside radical prostatectomy for staging purposes. The bundling relationship between 38771 and 55866 requires careful review of the NCCI table quarterly, as edits change. When lymph node dissection is a separately identifiable service with distinct documentation, a modifier may permit separate billing, but payer policy varies.
Common NCCI Edit Scenarios
- 51992 (Urethral Suspension) with 55866: Bundled relationship. Separate billing requires confirming the current modifier indicator and that documentation supports a distinct, separately identifiable procedure beyond the standard prostatectomy approach.
- 38771 (Pelvic Lymph Node Dissection) with 55866: Verify current NCCI table. Lymph node dissection performed for staging in prostate cancer may be separately reportable depending on the edit status and operative documentation.
- Other prostate codes (55801-55845): CMS NCCI Chapter 7 lists these codes as a group subject to bundling. Avoid billing multiple prostate procedure codes on the same date without confirming the NCCI edit status for each pair.
Efficient claims management software can flag NCCI edit conflicts before submission, reducing the manual burden on urology coders who must track quarterly NCCI table updates alongside annual CPT and ICD-10 code changes.
Reduce CPT 55866 Denials with Smarter Claims Workflows
Pabau's claims management tools help urology practices catch NCCI bundling conflicts, track modifier requirements, and document ICD-10 medical necessity codes before claim submission.
ICD-10 Diagnosis Codes Supporting Medical Necessity for CPT Code 55866
CPT Code 55866 requires a supporting ICD-10-CM diagnosis code that establishes medical necessity. For radical prostatectomy, the primary diagnosis is almost always malignant neoplasm of the prostate. Submitting 55866 with a non-oncologic primary diagnosis, or with a diagnosis code that does not appear on the applicable Local Coverage Determination (LCD) covered code list, is the most common medical necessity denial scenario for this procedure.
| ICD-10-CM Code | Description | Use Case with 55866 |
|---|---|---|
| C61 | Malignant neoplasm of prostate | Primary diagnosis for curative-intent radical prostatectomy |
| Z87.430 | Personal history of prostate cancer | Secondary/monitoring code; not sufficient alone as primary dx |
| D07.5 | Carcinoma in situ of prostate | May support surgical intervention in select cases |
| N40.1 | Benign prostatic hyperplasia with lower urinary tract symptoms | Supports 55867 (simple), NOT 55866 (radical) |
A well-documented denial pattern involves claims submitted with bladder cancer diagnosis codes (such as C67.9 or C67.2) when CPT Code 55866 was billed. Per community coding resources, some MAC LCDs for this procedure list only gender identity-related diagnoses as covered indications in certain jurisdictions, which has caused denials for prostate cancer cases where the LCD was misapplied. If CPT Code 55866 is denied for medical necessity when billed with C61, the appeal should include the operative report, pathology report, and the relevant LCD to demonstrate that prostate malignancy is a covered indication under the applicable MAC’s policy. Understanding the specific ICD-10 diagnosis code requirements per MAC jurisdiction is critical for avoiding these errors.
LCD and NCD awareness: Local Coverage Determinations vary by MAC jurisdiction. Before submitting CPT Code 55866, verify the applicable MAC’s LCD for prostatectomy procedures to confirm which ICD-10 codes are listed as covered indications. What is covered under one MAC may differ from another. Commercial payer policies add another layer of variation, and prior authorization requirements differ substantially by plan.
Pro Tip
Review the applicable MAC LCD for prostatectomy before submitting CPT 55866. Print the covered diagnosis code list and cross-reference it against the admitting and discharge diagnoses in the operative record. A mismatch between the billed ICD-10 code and the LCD covered list is the fastest path to a medical necessity denial that takes 90 days to appeal.
Documentation Requirements for CPT Code 55866 Clean Claims
Incomplete operative documentation is the root cause of most CPT Code 55866 denials that survive the initial code selection and modifier review. Payers require specific elements in the operative report to validate the code selection, the inpatient setting, and any separately reported services. Practices that track documentation completeness before billing consistently see lower denial rates on high-value surgical codes. Structured documentation practices also support billing workflow efficiency across the practice.
- Surgical approach confirmation: The operative report must explicitly state “laparoscopic” approach. Retroperitoneal vs. transperitoneal approaches should both be documented; verify whether the payer distinguishes between them.
- Radical vs. simple intent: Documentation must state the intent was “radical” removal of the prostate, not simple subtotal resection. The word “radical” in the operative report supports 55866 over 55867.
- Nerve sparing: If nerve sparing was performed (unilateral or bilateral), document which neurovascular bundle(s) were preserved and the technique used. If nerve sparing was not possible, document why.
- Robotic assistance: Note the robotic system used (e.g., da Vinci Xi) and confirm it was the surgical system, not just a camera or positioning aid. This supports the “robotic assistance, when performed” language in the descriptor.
- Separately reported services: If lymph node dissection (38771) or urethral suspension (51992) is separately billed, the operative note must describe these as distinct, separately identifiable procedures with their own indications, technique, and outcome documentation.
- Pathology report: For medical necessity support, include the pre-operative biopsy pathology confirming prostate malignancy. Some payers request this as part of prior authorization or upon post-payment audit.
Tracking documentation completion rates against claim outcomes helps identify which surgeons or procedural scenarios generate the highest denial rates. Practices that implement a pre-bill documentation checklist for 55866 can use accurate code documentation frameworks adapted from other high-complexity surgical specialties.
Prior Authorization and Payer-Specific Requirements
Prior authorization requirements for CPT Code 55866 vary significantly by payer. Medicare does not require prior authorization for inpatient surgical procedures under the traditional fee-for-service program, but Medicare Advantage plans frequently impose their own prior authorization requirements. Commercial payers including Kaiser Permanente require prior authorization for facility-based surgical procedures in this category, as reflected in their published prior authorization lists.
For commercial payer authorization requests, standard documentation packages for CPT Code 55866 typically include the following elements:
- Pre-operative prostate biopsy pathology report confirming malignancy
- Pre-operative PSA level and Gleason score
- Staging workup documentation (MRI, bone scan if applicable)
- Physician attestation of surgical candidacy and treatment plan
- Operative approach plan (laparoscopic, robotic-assisted)
Oregon’s Health Evidence Review Commission (HERC) evaluates value-based benefit coverage for surgical procedures including prostatectomy. Practices billing for Oregon Medicaid patients should verify current HERC coverage policies, as benefit coverage may vary from standard Medicare fee-for-service policy. Always confirm authorization before scheduling to avoid non-covered service write-offs on procedures with reimbursement in the high four figures per claim.
Expert Picks
Need a broader reference for urology billing codes? IVF CPT Codes covers the documentation and billing structure for other complex surgical procedures that share similar prior authorization and NCCI complexity.
Looking to streamline your practice’s claims workflow? Claims Management Software from Pabau automates claim tracking, modifier flagging, and denial follow-up for high-value procedure codes.
Managing documentation for multiple procedure codes? ICD-10 Code Documentation Guides explain how to pair diagnosis codes accurately with procedure codes across specialties to support medical necessity on complex claims.
Conclusion
CPT Code 55866 is one of the highest-value codes in urology billing, and it carries proportional documentation and compliance requirements. Getting the radical vs. simple distinction right, confirming inpatient-only placement, verifying NCCI edits before submitting concurrent codes, and pairing the claim with the correct ICD-10 diagnosis code are the four decisions that determine whether the claim pays clean or enters a denial cycle that can take months to resolve.
Pabau’s claims management tools support urology practices in tracking modifier requirements, flagging bundling conflicts before submission, and maintaining audit-ready documentation for high-value surgical codes like CPT Code 55866. To see how Pabau handles complex claims workflows for surgical specialties, book a demo.
Frequently Asked Questions
CPT Code 55866 is used to report a laparoscopic radical prostatectomy performed via a retropubic approach, including nerve-sparing technique and robotic assistance when used. It applies primarily to prostate cancer cases where the surgical intent is curative removal of the entire prostate gland.
Yes. The descriptor explicitly includes “robotic assistance, when performed,” meaning the da Vinci system or equivalent is bundled into 55866 and cannot be separately billed. There is no add-on code for robotic assistance with this procedure.
CPT 55866 is for radical prostatectomy (cancer, curative intent, full gland removal with nerve sparing). CPT 55867, effective January 1, 2023, covers laparoscopic simple prostatectomy for non-oncologic indications such as BPH. Using 55866 for a BPH case is an upcoding error.
Yes, under current CMS policy, CPT Code 55866 appears on the Medicare inpatient-only (IPO) list. It cannot be billed in an ASC or outpatient setting for Medicare patients. The IPO list is updated annually, so confirm the current status each January before the first submission of the calendar year.
ICD-10-CM C61 (Malignant neoplasm of prostate) is the primary diagnosis code for CPT Code 55866 claims. D07.5 (Carcinoma in situ of prostate) may apply in select cases. Always verify the applicable MAC’s LCD covered diagnosis code list, as covered indications vary by jurisdiction.
NCCI bundles urethral suspension (CPT 51992) and certain other prostate procedure codes with CPT 55866. Per the CMS NCCI Policy Manual, Chapter 7, codes 52601-52649, 53850-53855, 55801-55845, 55866, and 55880 are listed as a group subject to bundling edits. Verify the current modifier indicator for each code pair quarterly before separate billing.